NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Oct 2026 · 9 Oct 2026, 04:19 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Dr. Lal Path Labs Ltd. · LALPATHLAB
✦ AI SummaryRegulatory
Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance under Regulation 74(5) for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
LALPATHLAB_09102026161947_74_5september302026.pdf
View document text
October 09, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Corporate Relationship Department
Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers
Bandra Kurla Complex, Bandra (E) Dalal Street
Mumbai – 400051 Mumbai- 400001
Symbol: LALPATHLAB Scrip Code: 539524
Sub: Compliance under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018
Dear Sir/ Madam,
Please find enclosed herewith a copy of the Certificate received from MUFG Intime India
Private Limited, Registrar & Share Transfer Agent (RTA) of the Company, confirming the
compliance under Regulation 74(5) of the SEBI (Depositories and Participants)
Regulations, 2018, for the quarter ended September 30, 2026.
This above is for your information and record.
Thanking You,
Yours Faithfully,
For Dr. Lal PathLabs Limited
Vinay Gujral
Company Secretary & Compliance Officer
Encl.: As Above
Classification: Confidential